Arlene Morris

Arlene M.
Morris currently works at Willow Advisors LLC, as Chief Executive Officer from 2015, Medical University of South Carolina Foundation, as Chairman-Research & Development Foundation, TC Biopharm (Holdings) Plc, as Chairman from 2023, Palatin Technologies, Inc., as Independent Director from 2015, Viveve, Inc., as Independent Director from 2016, Cogent Biosciences, Inc., as Independent Director from 2019, Viridian Therapeutics, Inc., as Independent Director from 2018, Charleston Animal Society, as Director from 2022, and Edgewise Therapeutics, Inc., as Independent Director from 2024.
Ms. Morris also formerly worked at Syndax Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2012 to 2015, Affymax, Inc., as President, Chief Executive Officer & Director from 2003 to 2011, Clearview Projects, Inc., as President & Chief Executive Officer from 2002 to 2004, Nuon Therapeutics, Inc., as Chairman, MediciNova, Inc., as Independent Director from 2011 to 2013, Biodel, Inc., as Director from 2015 to 2016, Biotechnology Innovation Organization, as Director from 2006 to 2011, MUSC Foundation for Research Development, as Director from 2012 to 2022, Humane Society of Silicon Valley, as Director from 2009 to 2011, Dimension Therapeutics, Inc., as Independent Director from 2015 to 2018, Neovacs, Inc., as Director from 2011 to 2021, Viveve Medical, Inc., as Independent Director from 2016 to 2022, Neovacs SA, as Independent Director from 2011 to 2021, Coulter Pharmaceuticals, Inc., as Senior Vice President-Business Development from 1996 to 2001, Carlow University Of, as Trustee from 2016 to 2022, Scios, Inc., as Senior Vice President-Business Development from 1993 to 1996, and Johnson & Johnson, as Vice President-Business Development from 1977 to 1993.
Ms. Morris received her undergraduate degree from Carlow College and undergraduate degree from Western New England University.